MBAL:CA:TSX-Mackenzie Balanced Allocation ETF (CAD)

ETF | Others |

Last Closing

CAD 25.32

Change

-0.10 (-0.39)%

Market Cap

CAD 0.12B

Volume

3.22K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-11 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

-0.19 (-0.56%)

CAD 6.78B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.01%)

CAD 6.30B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.09 (+0.32%)

CAD 6.19B
PHYS-U:CA Sprott Physical Gold Trust

+0.16 (+0.71%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.19 (-0.54%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

-0.01 (-0.02%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.43 (+1.62%)

CAD 3.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

CAD 3.55B
PSLV-U:CA Sprott Physical Silver Trust

+0.29 (+2.67%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.01 (-0.04%)

CAD 2.78B

ETFs Containing MBAL:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.04% 49% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.04% 49% F 48% F
Trailing 12 Months  
Capital Gain 9.42% 67% D+ 59% D-
Dividend Return 2.39% 51% F 37% F
Total Return 11.82% 68% D+ 57% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 3.04% 48% F 43% F
Dividend Return 3.47% 46% F 37% F
Total Return 0.43% 59% D- 24% F
Risk Return Profile  
Volatility (Standard Deviation) 9.42% 55% F 76% C+
Risk Adjusted Return 36.87% 41% F 48% F
Market Capitalization 0.12B 66% D+ 37% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.